Chen Schor Insider Trading $EPIX EPIX Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Chen Schor.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Chen Schor. Chen Schor is Chief Business Officer in EPIX Pharmaceuticals, Inc. ($EPIX) and Director in BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) and Former President and CEO in SYNTA PHARMACEUTICALS CORP ($SNTA) and President and CEO in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Karyopharm Therapeutics Inc. ($KPTI) and President & CEO in Adicet Bio, Inc. ($TORC) and President and CEO in resTORbio, Inc. ($TORC) and See Remarks in resTORbio, Inc. ($TORC).
Chen Schor in EPIX Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Chen Schor: Chief Business Officer
Holdings: 145,719 shares
Current Value: $281,238
Latest Transaction: Feb 26 2009
$EPIX Market Capitalization: $60.52M
$EPIX Previous Close: $1.93
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Chen Schor in EPIX Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, BCLI, EPIX, KPTI, SNTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | M | 0.00 | 8,750 | 0 | 8,750 | |
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Payment of Exercise | F | 0.46 | 3,294 | 1,515 | 145,719 | 149 K to 145.7 K (-2.21 %) |
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Buy | M | 0.00 | 8,750 | 0 | 149,013 | 140.3 K to 149 K (+6.24 %) |
| Jan 05 2009 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Payment of Exercise | F | 1.03 | 26,403 | 27,195 | 140,263 | 166.7 K to 140.3 K (-15.84 %) |
| Jan 05 2009 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Grant | A | 0.00 | 63,700 | 0 | 166,666 | 103 K to 166.7 K (+61.87 %) |
| Feb 26 2008 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
| Feb 26 2008 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 3.15 | 40,000 | 126,000 | 40,000 | |
| Jan 03 2008 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Grant | A | 3.08 | 16,029 | 49,369 | 102,966 | 86.9 K to 103 K (+18.44 %) |
| Feb 07 2007 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 6.50 | 17,093 | 111,105 | 17,093 | |
| Feb 07 2007 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 6.50 | 19,720 | 128,180 | 19,720 | |
| Nov 28 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | M | 0.98 | 3,000 | 2,940 | 57,398 | |
| Nov 28 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Buy | M | 0.98 | 3,000 | 2,940 | 86,937 | 83.9 K to 86.9 K (+3.57 %) |
| Nov 06 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | M | 0.98 | 15,000 | 14,700 | 1,720 | |
| Nov 06 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Buy | M | 0.98 | 15,000 | 14,700 | 83,937 | 68.9 K to 83.9 K (+21.76 %) |
| Aug 21 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 7.20 | 30,000 | 216,000 | 30,000 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 1.74 | 27,962 | 48,654 | 27,962 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 0.98 | 81,235 | 79,610 | 81,235 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 0.98 | 75,398 | 73,890 | 75,398 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 2.18 | 6,888 | 15,016 | 6,888 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 2.18 | 114 | 249 | 114 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Option Exercise | A | 2.18 | 16,073 | 35,039 | 16,073 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Schor Chen | Chief Business Offi ... | Grant | A | 0.00 | 68,940 | 0 | 68,940 | 0 to 68.9 K |
Page: 1